Ventas Inc
F:VEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Ventas Inc
F:VEN
|
US |
|
Galderma Group AG
F:PY30
|
CH |
Intrinsic Value
The intrinsic value of 
Ventas Inc (VEN) under the Base Case is 70.7 EUR per share.
Compared with the current market price of 73.22 EUR, the stock appears
Overvalued by 3% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Ventas Does
Ventas is a real estate investment trust that owns healthcare properties. Its portfolio includes senior housing communities, medical office buildings, and life science or research facilities. In simple terms, it rents specialized buildings to healthcare operators and collects rent from them, rather than running the care facilities itself.
- Headquarters
- United States of America US
- Employees
- 542
- IPO date
- Apr 2, 1992
Ventas has no economic moat
Operators and tenants can choose among similar healthcare properties offered by other landlords, so Ventas does not have a unique service that keeps them tied to its buildings. Its size and name do not, by themselves, prevent competing property owners from winning tenants or earning similar returns.
Read the full moat analysis
Revenue & Expenses Breakdown
Ventas Inc
Earnings Waterfall
Ventas Inc
The intrinsic value for Ventas Inc (VEN) under the Base Case is 70.7 EUR.
Compared with the current market price of 73.22 EUR, the stock appears Overvalued by 3% .